HIBS seeks daily investment results, before fees and expenses, equal to 300% of the inverse of the daily performance of the S&P 500 High Beta Index. The index comprises the 100 stocks in the S&P 500 with the highest sensitivity to broad market movements, or beta, over the prior 12 months. Because it targets a -3x daily multiple, the fund moves roughly three times as much as the index on any single day, in the opposite direction.
The fund is structured as a non-diversified, leveraged inverse exchange-traded fund (ETF) with a net expense ratio of 1.06%. Rather than shorting the 100 underlying names directly, HIBS obtains its exposure primarily through swap agreements, with the bulk of its assets held in cash and Treasury money-market instruments. The underlying index is heavily weighted toward information technology—roughly 40% of holdings—followed by financials, consumer discretionary, and industrials. Prominent high-beta constituents include AMD, MU, TSLA, and MRNA. This concentrated, growth-oriented composition explains why the fund amplifies moves in the most volatile corner of the U.S. large-cap market.
Over the trailing 30 days, HIBS rose from roughly $15.61 to about $21.92, a gain of approximately 40%. The advance was not linear: the fund spiked above $22 in mid-October, pulled back toward $18.60, and then recovered into early November. The move reflects a pronounced selloff in the underlying high-beta index, which HIBS compounds at three times daily inverse exposure.
The trailing three-month picture is more nuanced. From approximately $19.97 in early August to roughly $21.92, HIBS gained about 10% over the quarter, but the path was exceptionally volatile. The fund slid to a low near $15.22 in early October before rallying sharply. In other words, the quarter was defined less by a steady trend than by a sharp risk-off shock to high-beta equities followed by a partial stabilization.
The recent surge was driven by a decisive rotation out of high-beta growth stocks. Several macroeconomic and market forces converged. Long-term Treasury yields climbed to multi-decade highs in early October, with the 10-year yield briefly touching the low-to-mid 5% range, which disproportionately pressures long-duration, high-valuation growth equities. A hotter-than-expected consumer inflation report reinforced expectations that interest rates could remain elevated.
At the same time, concerns over debt-funded AI infrastructure builders intensified. Names such as CRWV saw their bonds trade at stressed yields and their equities fall sharply, triggering a broader de-risking across speculative technology and momentum holdings. Because information technology dominates the S&P 500 High Beta Index, the index's decline was outsized relative to the broader S&P 500, which stayed near record highs. As the index fell, HIBS's -3x daily structure amplified the move, producing the fund's roughly 40% advance.
The broader three-month trend reflects a deeper shift in market leadership that began to crystallize in the fourth quarter. After more than a year of high-beta and AI-driven outperformance, investors rotated toward low-volatility, quality, and defensive segments as rates rose and inflation concerns resurfaced. High-beta ETFs underperformed low-volatility strategies by a wide margin during October, even as the capitalization-weighted S&P 500 remained resilient.
For HIBS, this rotation provided a tailwind that was partially offset by periodic rebounds in the underlying index. The fund's leveraged inverse structure means it tends to benefit most during sustained, one-directional declines in high-beta names and to lag during sharp relief rallies. Over the quarter, the net result was a volatile but positive gain of roughly 10%.
Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, AI-generated signals, and performance characteristics. The tool is designed to surface trending securities, breakout candidates, and tactical opportunities more efficiently than manual screening, and it can be applied to leveraged and inverse products such as HIBS as well as conventional funds. For investors seeking to complement their own research with systematic, data-driven screening, the AI Screener offers a practical starting point.
The most important factors for HIBS going forward are the trajectory of long-term interest rates and inflation, which have been the dominant forces behind the high-beta rotation. A sustained rise in Treasury yields would likely continue to pressure growth and momentum names, while any meaningful decline in yields could trigger sharp rallies in the underlying index and weigh on HIBS.
Investors should also monitor the health of AI-infrastructure financing and earnings trends among the largest high-beta technology and semiconductor holdings, as these names drive a disproportionate share of index movement. Capital flows into and out of defensive versus speculative segments, along with oil prices and geopolitical developments, remain key sentiment gauges. Finally, because HIBS compounds daily, its returns can diverge significantly from three times the index's cumulative move over periods longer than a single day—an essential consideration for anyone holding the fund beyond an intraday or short-term horizon.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HIBS saw its Momentum Indicator move above the 0 level on October 30, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In 80 of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The Moving Average Convergence Divergence (MACD) for HIBS just turned positive on October 30, 2026. Looking at past instances where HIBS's MACD turned positive, the stock continued to rise in 48 of 52 cases over the following month. The odds of a continued upward trend are 90%.
HIBS moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HIBS crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 18 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +21.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIBS advanced for three days, in 239 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
The Aroon Indicator entered an Uptrend today. In 108 of 120 cases where HIBS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The 10-day RSI Indicator for HIBS moved out of overbought territory on October 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 23 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIBS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
HIBS broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Category Trading